Faecal microbiota transplantation for Clostridium difficile infection in the United Kingdom

Clinical Microbiology and Infection

Volumn 21, Issue 6, 2015, Pages 578-582

  Porter, R J ^a   Fogg, C ^b  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Clostridium difficile infection; Faecal microbiota barriers; Faecal microbiota physician attitudes; Faecal microbiota transplantation; Faecal microbiota uptake

Indexed keywords

BACITRACIN; COLESTYRAMINE; FIDAXOMICIN; FUSIDATE SODIUM; IMMUNOGLOBULIN; METRONIDAZOLE; NITAZOXANIDE; RIFAXIMIN; TEICOPLANIN; VANCOMYCIN;

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; DONOR SELECTION; FEASIBILITY STUDY; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; GASTROENTEROLOGIST; HEALTH CARE SURVEY; HUMAN; MEDICAL SPECIALIST; NATIONAL HEALTH SERVICE; PATIENT ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TRANSPLANTATION; UNITED KINGDOM; CLOSTRIDIUM INFECTIONS; ENTEROCOLITIS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; QUESTIONNAIRE; UTILIZATION;

CLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; ENTEROCOLITIS; FECAL MICROBIOTA TRANSPLANTATION; HUMANS; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM;

EID: 84930817225     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.01.020     Document Type: Article

References (23)

1. Pépin J., Valiquette L., Alary M.-E., Villemure P., Pelletier A., Forget K., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004, 171:466-472.
2. Wilcox M.H., Shetty N., Fawley W.N., Shemko M., Coen P., Birtles A., et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 2012, 55:1056-1063.
3. Miller M., Gravel D., Mulvey M., Taylor G., Boyd D., Simor A., et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010, 50:194-201.
4. Hensgens M.P.M., Goorhuis A., Dekkers O.M., van Benthem B.H.B., Kuijper E.J. All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. Clin Infect Dis 2013, 56:1108-1116.
5. Wiegand P.N., Nathwani D., Wilcox M.H., Stephens J., Shelbaya A., Haider S. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. JHosp Infect 2012, 81:1-14.
6. Ghantoji S.S., Sail K., Lairson D.R., DuPont H.L., Garey K.W. Economic healthcare costs of Clostridium difficile infection: a systematic review. JHosp Infect 2010, 74:309-318.
7. Dubberke E.R., Olsen M.A. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012, 55(Suppl.2):S88-S92.
8. Konijeti G.G., Sauk J., Shrime M.G., Gupta M., Ananthakrishnan A.N. Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis. Clin Infect Dis 2014, 58:1507-1514.
9. Vardakas K.Z., Polyzos K.A., Patouni K., Rafailidis P.I., Samonis G., Falagas M.E. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents 2012, 40:1-8.
10. Abou Chakra C.N., Pepin J., Sirard S., Valiquette L. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One 2014, 9:e98400.
11. Gough E., Shaikh H., Manges A.R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011, 53:994-1002.
12. Van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., deVos W.M., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. NEngl J Med 2013, 368:407-415.
13. Zipursky J.S., Sidorsky T.I., Freedman C.A., Sidorsky M.N., Kirkland K.B. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis 2012, 55:1652-1658.
14. Zipursky J.S., Sidorsky T.I., Freedman C.A., Sidorsky M.N., Kirkland K.B. Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection. Can J Gastroenterol Hepatol 2014, 28:319-324.
15. Jiang Z.D., Hoang L.N., Lasco T.M., Garey K.W., Dupont H.L. Physician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area. Clin Infect Dis 2013, 56:1059-1060.
16. Petrof E.O., Gloor G.B., Vanner S.J., Weese S.J., Carter D., Daigneault M.C., et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'rePOOPulating' the gut. Microbiome 2013, 1:3.
17. Hamilton M.J., Weingarden A.R., Sadowsky M.J., Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012, 107:761-767.
18. Youngster I., Sauk J., Pindar C., Wilson R.G., Kaplan J.L., Smith M.B., et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 2014, 58:1515-1522.
19. Youngster I., Russell G.H., Pindar C., Ziv-Baran T., Sauk J., Hohmann E.L. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014, 312:1772-1778.
20. Debast S.B., Bauer M.P., Kuijper E.J. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014, 20(Suppl.2):1-26.
21. Kump P.K., Krause R., Allerberger F., Högenauer C. Faecal microbiota transplantation-the Austrian approach. Clin Microbiol Infect 2014, 20:1106-1111.
22. Lagier J.C. Faecal microbiota transplantation: from practice to legislation before considering industrialization. Clin Microbiol Infect 2014, 20:1112-1118.
23. Aroniadis O.C., Brandt L.J. Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease. Gastroenterol Hepatol 2014, 10:230-237.